vs

Side-by-side financial comparison of MAXCYTE, INC. (MXCT) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.

Soluna Holdings, Inc is the larger business by last-quarter revenue ($8.4M vs $4.8M, roughly 1.8× MAXCYTE, INC.). MAXCYTE, INC. runs the higher net margin — -200.5% vs -284.7%, a 84.2% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs -20.9%). MAXCYTE, INC. produced more free cash flow last quarter ($-2.9M vs $-6.8M). Over the past eight quarters, MAXCYTE, INC.'s revenue compounded faster (-7.4% CAGR vs -8.8%).

MaxCyte Inc. is a global biotechnology company focused on developing cell engineering platforms and enabling technologies for cell and gene therapy advancement. Its proprietary non-viral cell modification systems are widely used by pharmaceutical, biotech and life science research entities to develop immunotherapies, gene-edited treatments and next-generation biologic drugs from preclinical research through commercialization.

MXCT vs SLNH — Head-to-Head

Bigger by revenue
SLNH
SLNH
1.8× larger
SLNH
$8.4M
$4.8M
MXCT
Growing faster (revenue YoY)
SLNH
SLNH
+32.8% gap
SLNH
11.8%
-20.9%
MXCT
Higher net margin
MXCT
MXCT
84.2% more per $
MXCT
-200.5%
-284.7%
SLNH
More free cash flow
MXCT
MXCT
$3.9M more FCF
MXCT
$-2.9M
$-6.8M
SLNH
Faster 2-yr revenue CAGR
MXCT
MXCT
Annualised
MXCT
-7.4%
-8.8%
SLNH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MXCT
MXCT
SLNH
SLNH
Revenue
$4.8M
$8.4M
Net Profit
$-9.6M
$-24.0M
Gross Margin
9.5%
Operating Margin
-234.5%
-92.5%
Net Margin
-200.5%
-284.7%
Revenue YoY
-20.9%
11.8%
Net Profit YoY
9.4%
-233.2%
EPS (diluted)
$-1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MXCT
MXCT
SLNH
SLNH
Q4 25
$4.8M
Q3 25
$4.6M
$8.4M
Q2 25
$5.8M
$6.2M
Q1 25
$5.7M
$5.9M
Q4 24
$6.1M
$8.3M
Q3 24
$5.6M
$7.5M
Q2 24
$5.0M
$9.7M
Q1 24
$5.6M
$12.5M
Net Profit
MXCT
MXCT
SLNH
SLNH
Q4 25
$-9.6M
Q3 25
$-12.4M
$-24.0M
Q2 25
$-12.4M
$-7.4M
Q1 25
$-10.3M
$-7.6M
Q4 24
$-10.6M
$-40.0M
Q3 24
$-11.6M
$-7.2M
Q2 24
$-9.4M
$-10.9M
Q1 24
$-9.5M
$-5.3M
Gross Margin
MXCT
MXCT
SLNH
SLNH
Q4 25
Q3 25
9.5%
Q2 25
6.3%
Q1 25
5.7%
Q4 24
-360.8%
Q3 24
-39.1%
Q2 24
34.6%
Q1 24
45.4%
Operating Margin
MXCT
MXCT
SLNH
SLNH
Q4 25
-234.5%
Q3 25
-307.4%
-92.5%
Q2 25
-244.3%
-107.6%
Q1 25
-214.1%
-120.9%
Q4 24
-213.1%
-426.0%
Q3 24
-250.4%
-119.8%
Q2 24
-241.0%
-38.0%
Q1 24
-219.8%
3.2%
Net Margin
MXCT
MXCT
SLNH
SLNH
Q4 25
-200.5%
Q3 25
-269.7%
-284.7%
Q2 25
-212.2%
-119.9%
Q1 25
-178.7%
-127.3%
Q4 24
-175.0%
-483.8%
Q3 24
-205.9%
-95.5%
Q2 24
-188.8%
-112.4%
Q1 24
-170.6%
-41.9%
EPS (diluted)
MXCT
MXCT
SLNH
SLNH
Q4 25
Q3 25
$-0.12
$-1.14
Q2 25
$-0.12
$-0.93
Q1 25
$-1.21
Q4 24
$-7.14
Q3 24
$-0.11
$-1.56
Q2 24
$-0.09
$-3.62
Q1 24
$-2.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MXCT
MXCT
SLNH
SLNH
Cash + ST InvestmentsLiquidity on hand
$103.0M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$171.5M
$14.5M
Total Assets
$202.5M
$152.0M
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MXCT
MXCT
SLNH
SLNH
Q4 25
$103.0M
Q3 25
$105.7M
Q2 25
$126.6M
Q1 25
$138.3M
Q4 24
$154.5M
Q3 24
$153.8M
Q2 24
$157.3M
Q1 24
$157.5M
Total Debt
MXCT
MXCT
SLNH
SLNH
Q4 25
Q3 25
$13.3M
Q2 25
$10.0M
Q1 25
$10.2M
Q4 24
$7.1M
Q3 24
$8.1M
Q2 24
$9.0M
Q1 24
Stockholders' Equity
MXCT
MXCT
SLNH
SLNH
Q4 25
$171.5M
Q3 25
$180.3M
$14.5M
Q2 25
$190.7M
$-19.5M
Q1 25
$199.4M
$-16.1M
Q4 24
$206.3M
$-12.5M
Q3 24
$213.3M
$20.9M
Q2 24
$221.3M
$24.4M
Q1 24
$226.4M
$21.5M
Total Assets
MXCT
MXCT
SLNH
SLNH
Q4 25
$202.5M
Q3 25
$213.5M
$152.0M
Q2 25
$219.8M
$92.0M
Q1 25
$230.0M
$90.0M
Q4 24
$239.5M
$88.0M
Q3 24
$248.6M
$97.3M
Q2 24
$251.5M
$98.7M
Q1 24
$257.9M
$90.6M
Debt / Equity
MXCT
MXCT
SLNH
SLNH
Q4 25
Q3 25
0.92×
Q2 25
Q1 25
Q4 24
Q3 24
0.39×
Q2 24
0.37×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MXCT
MXCT
SLNH
SLNH
Operating Cash FlowLast quarter
$-2.7M
$-2.2M
Free Cash FlowOCF − Capex
$-2.9M
$-6.8M
FCF MarginFCF / Revenue
-61.0%
-81.4%
Capex IntensityCapex / Revenue
4.8%
55.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-36.2M
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MXCT
MXCT
SLNH
SLNH
Q4 25
$-2.7M
Q3 25
$-7.5M
$-2.2M
Q2 25
$-9.9M
$-1.1M
Q1 25
$-14.4M
$-177.0K
Q4 24
$-7.8M
$-5.1M
Q3 24
$-4.4M
$61.0K
Q2 24
$-4.8M
$-7.3M
Q1 24
$-10.6M
$3.9M
Free Cash Flow
MXCT
MXCT
SLNH
SLNH
Q4 25
$-2.9M
Q3 25
$-7.8M
$-6.8M
Q2 25
$-10.4M
$-9.7M
Q1 25
$-15.1M
$-4.0M
Q4 24
$-8.0M
$-13.9M
Q3 24
$-4.8M
$-3.4M
Q2 24
$-5.1M
$-7.6M
Q1 24
$-11.4M
$3.3M
FCF Margin
MXCT
MXCT
SLNH
SLNH
Q4 25
-61.0%
Q3 25
-168.5%
-81.4%
Q2 25
-179.2%
-156.8%
Q1 25
-262.3%
-67.1%
Q4 24
-131.6%
-168.3%
Q3 24
-85.5%
-44.8%
Q2 24
-103.3%
-78.2%
Q1 24
-203.6%
26.5%
Capex Intensity
MXCT
MXCT
SLNH
SLNH
Q4 25
4.8%
Q3 25
6.5%
55.2%
Q2 25
10.0%
139.0%
Q1 25
11.4%
64.2%
Q4 24
2.4%
107.0%
Q3 24
7.2%
45.6%
Q2 24
5.9%
2.5%
Q1 24
14.4%
4.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MXCT
MXCT

Products$4.2M87%
Other$634.0K13%

SLNH
SLNH

Data Hosting Revenue$5.3M62%
Cryptocurrency Mining Revenue$2.8M33%
Other$389.0K5%

Related Comparisons